contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


modular-finance-ir-consensus-cellavision-consensus-estimates-q4-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company's products are aimed at healthcare institutions and laboratories. The business is global, with a primary presence in Europe, North America and Asia. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

CellaVision

Estimates compiled by Modular Finance on behalf of CellaVision.Number of contributors: 4 (all of which have been updated or confirmed before the report)KPI (MSEK, unless otherwise specified)...

<div class="mfn-body"><p>Estimates compiled by Modular Finance on behalf of CellaVision.</p><p>Number of contributors: 4 (all of which have been updated or confirmed before the report)</p><table><tbody><tr><td rowspan="1" colspan="1"><strong>KPI (MSEK, unless otherwise specified)</strong></td><td rowspan="1" colspan="1" align="right"><strong>Q4 2024E</strong></td></tr><tr><td rowspan="1" colspan="1">Net sales</td><td rowspan="1" colspan="1" align="right">202</td></tr><tr><td rowspan="1" colspan="1">EBITDA margin, (%)</td><td rowspan="1" colspan="1" align="right">33.0</td></tr></tbody></table><p>More consensus estimates can be found on CellaVision’s webpage: <a rel="noopener" href="https://www.cellavision.com/investors/key-figures/analyst-consensus-figures">https://www.cellavision.com/investors/key-figures/analyst-consensus-figures</a></p><p>CellaVision’s Q4 report will be released on Thursday, February 6, at 7:20 CET.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/b5f8f5a2-67df-4a2d-a78f-35c26dafdfc4/cellavision-consensus-estimates-q4-2024.pdf" class="mfn-generated mfn-primary">CellaVision – Consensus estimates Q4 2024</a></p></div>

Modular Finance IR Consensus: CellaVision – Consensus estimates Q4 2024

Kun Wall Street yskii, on katseet syytä suunnata Eurooppaan

Friedrich Merzin “whatever it takes” -hetki

Antilla on asiaa: Miksi Kesko ja S-ryhmä hallitsevat surutta omaa markkinaansa?

Vaihteleva viikko takana, Wall Streetilla hermot koetuksella

USA: Hiljainen helpotuksen huokaus inflaatioluvuista

KPI (MSEK, unless otherwise specified)	Q4 2024E
Net sales	202
EBITDA margin, (%)	33.0